8 Mar 2019

Zim Laboratories Limited at CPHI Worldwide 2018

Anwar Daud, Managing Director of Zim Laboratories Limited, speaks with CPHI TV at CPHI Worldwide in Madrid.

Content provided by our supplier

Zim Laboratories Ltd.

  • IN
  • 2015
    On CPHI since

Other Content from Zim Laboratories Ltd. (1)

  • News ZIM Announces Submission of Marketing Authorization Application for 'Rizatriptan' orally dissolving film in Europe

    ZIM Laboratories Limited (ZIM) announced that it has filed the regulatory dossier for approval of Rizatriptan orally dissolving film in Europe.Rizatriptan orally dissolving film is a product developed using our Thinoral® technology which yields instantly wettable, rapidly dissolving, and stable films. The product is used in the treatment of migraine which is invariably associated with symptoms like nausea and vomiting.The fast dissolving features provides fast onset of action.